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10
Intervention consisted of group specific progressive balance, flexibility, strengthening, and 11 aerobic exercise conducted sitting or lying (NWB) or standing and walking (WB) three times a 12 week for 12 weeks.
13
Main Outcome Measures were six minute walk distance (SMW) and daily step counts. Results. The WB group showed greater gains than the NWB group over time in SMW and 17 average daily step count (p<0.05). The mean and 95% confidence intervals (CI) between group 18 difference over time was 29 (6 to 51) meters for the SMW distance and 1178 (150 to 2205) steps 19 for average daily step count. The NWB group showed greater improvements than the WB 20 group over time in hemoglobin A1c values (p<0.05). Duration and intensity were matched between groups as closely as possible. Target heart rate 109 was intended to be 60-70% of age-predicted maximum, and activity was adjusted to stay within 110 those limits using a heart rate monitor and a Rating of Perceived Exertion between 11-13 on a 6- Participants with footwear that did not meet the criteria were helped to select appropriate fitting 131 shoes.
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132
Weight Bearing Exercise Program
133
Baseline duration of walking was individually calculated based on participants' own 134 average daily step count collected over 7 days using the Step Watch Activity Monitor b .
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8
Non-weight Bearing Exercise Program
142
The NWB group conducted all exercises in a sitting or lying position. Step activity monitoring: Average daily step count was estimated using the StepWatch activity 158 monitor b , an accelerometer attached to the participant's ankle that provides a time stamped 159 recording of strides (1 stride equals 2 steps). We used an average steps/day for a 7 day period 160 collected over 14 days; a reliable and valid measure of overall activity levels. 11, 26 For a day to 161 be included, the activity had to be apparent for at least 8 hours a day, and at least 1 weekend day 162 was included in the 7 day average. Skin lesions on the lower leg were monitored to document the safety of the interventions.
176
All surfaces of the foot were photographed before and after treatment using a digital camera and Table 2 .
198
The WB group showed greater gains than the NWB group over time (significant 199 interactions) in the primary outcomes of SMW distance and average daily step count (p<.05).
200
The mean (95% CI) between group difference over time was 29 (6 to 51) meters for the SMW 201 distance and 1178 (150 to 2205) steps for average daily step count.
202
The NWB group showed greater improvements than the WB group over time (significant Adverse Events: There were a total of 13 lesions and 4 ulcers observed during the study (Table   207 3). One person in the WB group had a calf strain during treadmill walking, but was able to 208 continue to exercise with a lower intensity (shorter time on treadmill, fewer heel raises) and the the "Feet First" study. While the overall activity level is still low, these improvements are M A N U S C R I P T capacity, and that exercise should be tailored to match their personal goals.
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The lesions that occurred during this study generally were small, healed quickly (Table   246 3 was "just right" (Table 4 ). Furthermore, participants were under close supervision of their skin 261 and vital signs using a small group (1-4) approach, which seemed to foster a sense of safety, 262 community, and accountability.
263
Study Limitations
264
The study had a small number of participants and was not powered adequately to 265 determine group differences in secondary outcomes. Between group differences over time for the 266 primary variables, although significant, had a wide 95% CI with the potential for a low treatment 267 effect. We believe there is potential for greater improvement with a higher exercise intensity and 268 /or duration. The aerobic exercise duration, especially for the WB group, was not as much as we 269 had hoped. We underestimated number of additional steps needed for a 10% increase each week 270 because we based the increase on time duration of walking at a step rate of 100 steps per minute 271 (Appendix 3), but participants walked slower than that. 37 This study also had limited follow-up.
272
We focused on the controlled, short-term effects of moderate exercise in an understudied, high-273 risk population, but longer term follow-up with a larger sample size and greater exercise duration 274 is needed. Furthermore, we used a blinded tester for most measures, but we should have used a 275 blinded tester for the SMW test. We acknowledge this limitation but contend any bias was 276 minimized by using highly consistent and standardized instructions. . Finally, these participants M A N U S C R I P T were selected from a much broader range of people with DM+PN ( Figure 1 ) and results can be 278 generalized only to those meeting the inclusion and exclusion criteria of this study. Non-weight bearing intervention group N=14 M A N U S C R I P T M A N U S C R I P T In your opinion, how strenuous was the exercise program 
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